Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy-Reference-Cited by-同舟云学术

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy

Published:2008-12 Issue:3 Volume:62 Page:356-363
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Pallis A.G.,Agelaki S.,Kakolyris S.,Kotsakis A.,Kalykaki A.,Vardakis N.,Papakotoulas P.,Agelidou A.,Geroyianni A.,Agelidou M.,Hatzidaki D.,Mavroudis D.,Georgoulias V.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference28 articles.

1. Non small cell lung cancer;Ginsberg,1997

2. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis;Souquet;Lancet,1993

3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;BMJ,1995

4. Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial;Georgoulias;Lancet,2001

5. Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial;Georgoulias;J Clin Oncol,2005

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors of Post-chemoradiotherapy Pulmonary Complication in Locally Advanced Non–Small Cell Lung Cancer;Cancer Research and Treatment;2023-07-15

2. A novel nutritional parameters-based nomogram for predicting severe neutropenia after CAPEOX/XELOX or SOX adjuvant chemotherapy in gastric cancer patients;2023-02-14

3. A novel nutritional parameters-based nomogram for predicting severe neutropenia after CAPEOX/XELOX or SOX adjuvant chemotherapy in gastric cancer patients;2022-10-26

4. Retrospective analysis of efficacy and safety of oral paclitaxel for treatment of various cancers in dogs (2017–2021);Veterinary Medicine and Science;2022-05-27

5. Optimized Dosing: The Next Step in Precision Medicine in Non-Small-Cell Lung Cancer;Drugs;2021-12-11